Funding for this research was provided by:
Cancer Research UK (C30358/A29725)
Received: 26 January 2022
Accepted: 16 August 2022
First Online: 20 October 2022
: This study has been approved by the QResearch Scientific Committee on 8 July 2021. QResearch is a Research Ethics Approved Research Database, confirmed by the East Midlands – Derby Research Ethics Committee (research ethics reference: 18/EM/0400, project reference: OX30 DeLIVER). A dedicated webpage for this project has been created on the QResearch website ExternalRef removed. A lay summary of this project for the public audience is available on the webpage.
: Not applicable.
: JH-C is an unpaid director of QResearch, a not-for-profit organisation in a partnership between the University of Oxford and EMIS Health, who supply the QResearch database for this work. JH-C is a founder and shareholder of ClinRisk Ltd. and was its medical director until 31 May 2019. ClinRisk Ltd. produces open and closed source software to implement clinical risk algorithms into clinical computer systems including the original QCancer algorithms referred to above. Other authors have no interests to declare for this submitted work.